ArticleJournal of vascular surgery2016
Evolving practice pattern changes and outcomes in the era of hybrid aortic arch repair.
Article in Journal of vascular surgery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Endovascular arch repair using a novel single branch arch stent graft: 30-Day results from the chronic dissection arm of the NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness investigational device exemption study.JTCVS structural and endovascular · 2026Article
- Management of recurrent ascending aortic aneurysm with bovine arch and aberrant right subclavian artery utilizing bilateral carotid to subclavian transposition followed by thoracic endovascular aneurysm repair.Journal of vascular surgery cases and innovative techniques · 2026Article
- Long-term outcomes and prognostic factors of hybrid aortic arch repair: a 15-year cohort study.Frontiers in cardiovascular medicine · 2026Article
- Near-wall hemodynamic changes in subclavian artery perfusion induced by retrograde inner branched thoracic endograft implantation.JVS-vascular science · 2023Article
- Comprehensive review of hybrid aortic arch repair with focus on zone 0 TEVAR and our institutional experience.Frontiers in cardiovascular medicine · 2022Review
- Current state of hybrid solutions for aortic arch aneurysms.Annals of cardiothoracic surgery · 2021Review
- A Case of Type I Debranching Complicated by Anastomotic Pseudoaneurysm: Do Not Ask Too Much of the Ascending Aorta.Aorta (Stamford, Conn.) · 2019Article
- Outcomes Of Chimney Technique For Aortic Arch Diseases: A Single-Center Experience With 226 Cases.Clinical interventions in aging · 2019Article
- A review of endovascular treatment of thoracic aorta disease.Annals of the Royal College of Surgeons of England · 2018Article
- Long-term survival and related outcomes for hybrid versus traditional arch repair-a meta-analysis.Annals of cardiothoracic surgery · 2018Article
- Classic hybrid arch debranching (type I hybrid arch repair) without circulatory arrest.Annals of cardiothoracic surgery · 2018Article
Corrections and comments
- Commented on byDiscussion.2016
Authors and funding
7 authors.
Funding
Abstract
objectiveThe role of hybrid repair in the management of aortic arch pathology, and long-term outcomes with these techniques, remains uncertain. We report a decade of experience with hybrid arch repair (HAR) and assess institutional practice patterns with regard to the use of hybrid and open techniques.
methodsHybrid and open total and distal arch procedures performed between July 2005 and January 2015 were identified from a prospectively maintained, institutional aortic surgery database. Perioperative morbidity and mortality, freedom from reintervention, and long-term survival were calculated. Hybrid and open procedural volumes over the study period were assessed to evaluate for potential practice pattern changes.
resultsDuring the study period 148 consecutive procedures were performed for repair of transverse and distal aortic arch pathology, including 101 hybrid repairs and 47 open total or distal arch repairs. Patients in the hybrid repair group were significantly older with a greater incidence of chronic kidney disease, peripheral vascular disease, and chronic lung disease. Perioperative mortality and outcomes were not significantly different between the hybrid and open groups, aside from decreased median length of stay after hybrid repair. Need for subsequent reintervention was significantly greater after hybrid repair. Unadjusted long-term survival was superior after open repair (70% 5-year survival open vs 47% hybrid; P = .03), although aorta-specific survival was similar (98% 5-year aorta-specific survival open vs 93% hybrid; P = .59). Institutional use of HAR decreased over the final 3 years of the study, with an associated increased use of open total or distal arch repairs. This was primarily the result of decreased use of native zone 0 hybrid procedures. Concurrent with this apparent increased stringency around patient selection for HAR, perioperative morbidity and mortality was reduced, including avoidance of retrograde type A dissection.
conclusionsHAR remains a viable option for higher-risk patients with transverse arch pathology with perioperative outcomes and long-term aorta-specific survival similar to open repair, albeit at a cost of increased reintervention. This observational single-institution study would suggest decreased use in more recent years in favor of open repair due to avoidance of native zone 0 hybrid procedures. This decline in the institutional use of native zone 0 hybrid repairs was associated with improved perioperative outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.